Hooper Holmes (NYSEMKT:HH) released 2013 full-year financial results before the market opens. Hooper Holmes, Inc. (NYSEMKT:HH) shares after opening at $0.62 moved to $0.66 on last trade day and at the end of the day closed at $0.620. Company price to sales ratio in past twelve months was calculated as 0.60 and price to cash ratio as 6.47. Hooper Holmes, Inc. (NYSEMKT:HH) showed a negative weekly performance of -7.46%.
Chembio Diagnostics, Inc. (NASDAQ:CEMI) announced yesterday that its HIV 1/2 STAT-PAK® Assay received CE Mark approval from European regulators. Chembio Diagnostics Inc. (NASDAQ:CEMI) shares ended the day on $3.43. CEMI return on equity ratio is recorded as 2.70% and its return on assets is 2.20%. Chembio Diagnostics Inc. (NASDAQ:CEMI) yearly performance is -38.09%.
William Blair upgraded shares of STAAR Surgical Company (NASDAQ:STAA) from a market perform rating to an outperform rating in a research report released on Monday morning, TheFlyOnTheWall.com reports. STAAR Surgical Company (NASDAQ:STAA) shares moved up 5.97% in last trading session and was closed at $18.64, while trading in range of $17.76 – $18.66. STAAR Surgical Company (NASDAQ:STAA) year to date (YTD) performance is 15.13%.
Wedbush assumed coverage on shares of Foundation Medicine (NYSE:FMI) in a report released on Tuesday, Stock Ratings News reports. The firm issued an outperform rating and a $50.00 price objective on the stock. Foundation Medicine Inc. (NASDAQ:FMI) weekly performance is -21.77%. On last trading day company shares ended up $33.46. Foundation Medicine Inc. (NASDAQ:FMI) distance from 50-day simple moving average (SMA50) is 0.01%. Analysts mean target price for the company is $40.40.